January 2018 MHE0118_CV1-1.jpg
Four health programs successfully fight the opioid epidemicShocking opioid overdose statistics make it crucial to address the epidemic. Here are four programs to watch
Four PBM programs poised to rein in the opioid epidemicPBMs are in a unique position to help curb opioid abuse. Here are four programs that demonstrate promising outcomes.
How health execs can partner with pharmacists to address opioidsDirector of medication safety and quality for the American Society of Health-System Pharmacists shares how providers can better work with pharmacists to address the opioid epidemic.
Autoimmune drug pipeline highlightsMore targeted therapies for autoimmune diseases are on the horizon. Here’s what to anticipate in 2018.
Four therapeutic areas to watch in 2018Prepare for major pipeline developments in diabetes, autoimmune disorders, oncology, and COPD.
End-of-life care planning advancements: What health execs should knowMore awareness and new state laws regarding end-of-life treatment are affecting treatment approaches. Here’s what you need to know.
Eight ways doctors can address the opioid epidemicAs the opioid epidemic rages, doctors and hospitals should consider these tips and strategies employed by other organizations.
Will biosimilars deliver on expectations?This might be the year when it becomes clear, perhaps painfully so, whether or not biosimilars can deliver on cost savings expectations.
The top three pharmacy challenges of 2018Find out what challenges top the list, and what analysts say can be done about them.
Top 10 challenges for healthcare executives in 2018Managed Healthcare Executive board members identify top challenges. How does your list compare?